All Blogs

Mar 01, 2023

Evaluating the Key Trends and Developments in the Global Next-Generation Sequencing Market


Feb 28, 2023

SpringWorks’s Desmoid Tumors Therapeutic, Nirogacestat; Orphan Drug Designation to AskBio’s AB-1003; Mitsubishi Tanabe’s Phase 3 Trial of RADICAVA ORS in ALS; EU Orphan Drug Designation to Sage Therapeutics’s SAGE-718; FDA Fast Track Status to Biohaven’s Taldefgrobep Alfa


Feb 24, 2023

A Quick Recap from ASCO GU 2023: Prostate and Urothelial Cancer Highlights


Feb 27, 2023

Minimal Residual Disease (MRD) Testing: A Path to Cure Cancer?


Feb 24, 2023

Top 10 Expected Oncology Drug Launches in 2023


Feb 23, 2023

Medtronic’s Extravascular Defibrillator System; Stryker’s Q Guidance System for Cranial Applications; Synchrony Medical’s LibAirty™ Airway Clearance System Study; Cognito Therapeutics’s Pivotal Study HOPE Update; Dexcom’s G6 Continuous Glucose Monitoring System Launch in Singapore; Rhaeos Raised $10.5M in Series A Funding


Feb 22, 2023

How is Protein Supplements Market Evolving with the Ongoing Development?


Feb 21, 2023

Actinium Announces Phase III SIERRA Trial Results; FDA Approves Apellis’s Geographic Atrophy Drug; FDA Gives Green Light to Chiesi’s Lamzede; FDA Accepts NDA and Grants Priority Review for Avacincaptad Pegol; FDA Approves Travere’s Kidney Disorder Drug; Takeda Presents Phase 3 GRAPHITE Study Results


Feb 20, 2023

The Road Ahead for Donanemab: Will the Therapy be the Next Imminent Breakthrough in the Alzheimer’s Disease Treatment Landscape?


Feb 17, 2023

Changing Landscape of EBV-associated Diseases Treatment: Is T-cell Immunotherapy the Answer?